Helix Nanotechnologies logo

Helix NanotechnologiesNext-generation mRNA platform to solve cancer, COVID and climate.

Technology finds information and delivers physical products to us almost instantly. mRNA does the same for biology. At HelixNano, we see a world where treatments are cheap, progress is decentralized, and you can modify biology at the push of a button. By focusing on mRNA improvements from first principles, we’re getting there faster than we thought. Experiments that used to take months or years can be done in weeks and cost thousands instead of millions. The rate limiting step for our progress is now scientific curiosity. Rigid hierarchies and top-down decisions will miss the magic. Some of our most powerful technologies started out as side projects of junior team members. At HelixNano, every individual scientist can have a massive impact on the company's direction. And the more diverse our team, the faster we’ll find the really cool ideas. We've started rolling out some of our new tech — moving a COVID-19 vaccine candidate for the immunocompromised towards the clinic, and testing an intervention with massive environmental impact. But we’re scientists at heart, and team focus is solidly on the horizon.

2016-12-22
Active
Growth
W17
16
Healthcare
United States of AmericaAmerica / CanadaRemotePartly Remote
Helix Nanotechnologies screenshot
More About Helix Nanotechnologies

HelixNano: Revolutionizing mRNA Technologies

Pioneering the Future of Medicine

HelixNano is at the forefront of developing next-generation mRNA technologies, vaccines, and therapies designed to enhance the immune system's ability to combat diseases.

Key Features

  • Advanced mRNA technology
  • Cutting-edge vaccine development
  • Innovative therapeutic solutions
  • Robust research and development team
  • Focus on immune system augmentation

Use Cases

  • Disease prevention through advanced vaccines
  • Therapeutic interventions for chronic illnesses
  • Personalized medicine applications
  • Research and development in immunology
  • Clinical trials and product development

Pricing

HelixNano offers customized pricing plans tailored to the specific needs of research institutions, healthcare providers, and pharmaceutical companies. Contact us for detailed pricing information and to discuss your specific requirements.

Teams

HelixNano boasts a diverse and highly skilled team of experts dedicated to pushing the boundaries of mRNA technology. Our team includes:

  • Justin Huang, Bioinformatics Pathfinder
  • Nicole Camfield, Head of Operations
  • Arianna Sauceda, mRNA Explorer Scientist
  • Dario Davila, Molecular Inquirer
  • Julia Carvalho, COO
  • Cassandra Murray, Executive Assistant
  • Niko Radzinski, Metagenomic Navigator
  • Nikolai Eroshenko, Founder, CSO
  • Katherine Rowe, Cellular Alchemist
  • Kemo Jammeh, Molecular Explorer
  • Rachel Soo Hoo Smith, Climate Team Lead
  • Marianna Keaveney, Director of Clinical Product Development
  • Hannu Rajaniemi, Founder, CEO
  • Tao Qin, Lab Manager
  • Harriette Carrington, Clinical Product Development Project Manager
  • Taylor Gill, Molecular Engineering Lead
  • Everett Webster, Vaccine Scientist
  • Magno Kerr, Lab Operations Associate
  • Nikhil Dharm, RNA Tech Team Lead
  • Karen Smith, CMO

Join us in our mission to harness the power of mRNA technology to create a healthier future.